Is central nervous system an immune-privileged site?

Kathmandu University Medical Journal

Volumn 11, Issue 41, 2013, Pages 102-107

  Shrestha, R ^a,b,c   Millington, O ^c   Brewer, J ^d   Bushell, T ^c  

^a KATHMANDU UNIVERSITY SCHOOL OF MEDICAL SCIENCES   (Nepal)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Blood brain barrier; Central nervous system; Immune cells and lymphocytes; Immune privileged

Indexed keywords

ALPHA4 INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; MEDIATOR RELEASE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 84879269737     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v11i1.11055     Document Type: Article

References (93)

1. Weil ZM, Norman GJ, DeVries AC, Nelson RJ. The injured nervous system: a Darwinian perspective. Prog Neurobiol 2008; 86(1): 48-59.
2. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977; 25: 1-54.
3. Billingham RE, Boswell T. Studies on the problem of corneal homografts. Proc R Soc Lond B Biol Sci 1953; 141(904): 392-406.
4. Hawkins BT, Davis TP. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. Pharmacological Reviews 2005; 57(2): 173-185.
5. Weiss N, Miller F, Cazaubon S, Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 2009;1788(4): 842-57.
6. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006; 1(3): 223-36.
7. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002;38(6): 323-37.
8. Bernacki J, Dobrowolska A, Nierwinska K, Malecki A. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep 2008; 60(5): 600-22.
9. Abbott N. Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation. Cellular and Molecular Neurobiology 2005; 25(1): 5-23.
10. Petty MA, Lo EH. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 2002;68(5): 311-23.
11. Brightman MW, Kadota Y. Nonpermeable and permeable vessels of the brain. NIDA Res Monogr 1992; 120: 87-107.
12. Armulik A. Pericytes regulate the blood-brain barrier. Nature 2010; 468(7323):557-561.
13. Balabanov R, Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. Journal of Neuroscience Research 1998;53(6): 637-644.
14. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 2006;113(4): 477-85.
15. Bucky Jones T, Lucin KM, Popovich PG, Adriana del Rey GPC, Hugo OB. The Immune System of the Brain, in NeuroImmune Biology. Elsevier;2007p.127-144.
16. Kerschensteiner M, Meinl E, Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009; 158(3): 1122-32.
17. Straub RH, Westermann J, Scholmerich J, Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 1998;19(9): 409-13.
18. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunological Reviews 2006; 213(1): 48-65.
19. Hickey WF. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991; 1(2):97-105.
20. Reboldi A. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10(5):514-523.
21. Weller RO, Engelhardt B, Phillips MJ. Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS-Immune Pathways. Brain Pathology 1996;6(3):275-288.
22. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28(2): 254-60.
23. Laschinger M, Engelhardt B. Interaction of [alpha]4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. Journal of Neuroimmunology 2000;102(1):32-43.
24. Engelhardt B. T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments. Clinical and Experimental Neuroimmunology 2010;(2):79-93.
25. Engelhardt B, Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 2004;34(11):2955-63.
26. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76(2):301-14.
27. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends in Immunology 2007;28(1): 12-18.
28. Blalock JE. The syntax of immune-neuroendocrine communication. Immunology Today 1994;5(11):504-511.
29. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005;5(3):243-251.
30. Segerstrom SC, Miller GE. Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry. Psychological Bulletin 2004;130(4):601-630.
31. Konstantinos AP, Sheridan JF. Stress and influenza viral infection: modulation of proinflammatory cytokine responses in the lung. Respiration Physiology 2001;128(1): 71-77.
32. Miller AH. Glucocorticoid Receptors Are Differentially Expressed in the Cells and Tissues of the Immune System. Cellular Immunology 1998;186(1): 45-54.
33. Welniak LA, Sun R, Murphy WJ. The role of growth hormone in T-cell development and reconstitution. Journal of Leukocyte Biology 2002;71(3): 381-387.
34. Elenkov IJ, Chrousos GP. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity. Annals of the New York Academy of Sciences 2002;966(1):290-303.
35. Lai J-P, Douglas SD, Ho W-Z. Human lymphocytes express substance P and its receptor. Journal of Neuroimmunology 1998;86(1):80-86.
36. Radulovic M, Dautzenberg FM, Sydow S, Radulovic J, Spiess J. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. The Journal of Immunology 1999;162(5):3013-3021.
37. MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. The Journal of Experimental Medicine 1989;169(2):431-445.
38. Rosas-Ballina M. Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit. Science 2011;334(6052):98-101.
39. Madden KS, Felten DL. Experimental basis for neural-immune interactions. Physiological Reviews 1995;75(1):77-106.
40. Felten DL. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 1987;100: 225-60.
41. Boulanger LM, Shatz CJ. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 2004;5(7):521-531.
42. Deverman BE, Patterson PH. Cytokines and CNS Development. Neuron 2009;64(1):61-78.
43. Blalock JE, Smith EM. Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci U S A 1980;77(10):5972-4.
44. Carlson SL, Felten DL, Livnat S, Felten SY. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain, Behavior, and Immunity 1987;1(1): 52-63.
45. Dantzer R. Innate immunityat the forefrontofpsychoneuroimmunology. Brain, Behavior, and Immunity 2004;18(1):1-6.
46. Jiang C-L, Lu C-L, Liu X-Y. The molecular basis for bidirectional communication between the immune and neuroendocrine systems. Domestic Animal Endocrinology 1998;15(5):363-369.
47. Smith EM, Blalock JE. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A 1981;78(12):7530-4.
48. Crane JW, Buller KM, Day TA. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1β. The Journal of Comparative Neurology 2003;467(2): 232-242.
49. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005;29(2): 201-217.
50. McCann SM. Role of Cytokines in the Endocrine Systema. Annals of the New York Academy of Sciences 1994;741(1):50-63.
51. Hanisch U-K, Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Research Reviews 1995;21(3):246-284.
52. Sarder M, Saito H, Abe K. Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Research 1993;625(2):347-350.
53. Benveniste EN, Merrill JE. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 1986;321(6070): 610-613.
54. Sawada M, Suzumura A, Marunouchi T. Induction of Functional Interleukin-2 Receptor in Mouse Microglia. Journal of Neurochemistry 1995;64(5):1973-1979.
55. De Sarro GB, Masuda Y, Ascioti C, Audino MG, Nistico G. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology 1990; 29(2):167-179.
56. Besedovsky H. The immune response evokes changes in brain noradrenergic neurons. Science 1983;221(4610):564-566.
57. Zalcman S, Shanks N, Anisman H. Time-dependent variations of central norepinephrine and dopamine following antigen administration. Brain Research 1991;557(1-2):69-76.
58. Aloisi F, Ria F, Penna G, Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 1998;160(10):4671-80.
59. Greter M. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 2005;11(3):328-334.
60. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006;12(5):518-25.
61. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005;26(9): 485-95.
62. Lampson LA. Enhanced T Cell Migration to Sites of Microscopic CNS Disease: Complementary Treatments Evaluated by 2-and 3-D Image Analysis. Brain Pathology 1994;4(2):125-134.
63. Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003; 3(7):569-81.
64. Carrithers MD, Visintin I, Viret C, Janeway CA. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. Journal of Neuroimmunology 2002;129(1-2): 51-57.
65. Bartholomaus I. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009;462(7269):94-98.
66. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239(4837):290-2.
67. Piccio L. Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors. The Journal of Immunology 2002;168(4):1940-1949.
68. Kivisäkk P. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 2003;100(14):8389-94.
69. Seabrook TJ, Johnston M, Hay JB. Cerebral spinal fluid lymphocytes are part of the normal recirculating lymphocyte pool. J Neuroimmunol 1998;91(1-2):100-7.
70. Engelhardt B, Conley FK, Butcher EC. Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. Journal of Neuroimmunology 1994;51(2):199-208.
71. Jenkins MK. IN VIVO ACTIVATION OF ANTIGEN-SPECIFIC CD4 T CELLS. Annual Review of Immunology 2001. 19(1):23-45.
72. Axtell RC, Steinman L. Gaining entry to an uninflamed brain. Nat Immunol 2009;10(5):453-455.
73. Kerfoot SM, Kubes P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002;169(2):1000-6.
74. Engelhardt B. Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines. Journal of the Neurological Sciences 2008;274(1-2):23-26.
75. Engelhardt B. P-Selectin Glycoprotein Ligand 1 Is Not Required for the Development of Experimental Autoimmune Encephalomyelitis in SJL and C57BL/6 Mice. The Journal of Immunology 2005;175(2):1267-1275.
76. Engelhardt B, Vestweber D, Hallmann R, Schulz M. E, and P-Selectin Are Not Involved in the Recruitment of Inflammatory Cells Across the Blood-Brain Barrier in Experimental Autoimmune Encephalomyelitis. Blood 1997;90(11):4459-4472.
77. Döring A, Wild M, Vestweber D, Deutsch U, Engelhardt B. E-and P-Selectin Are Not Required for the Development of Experimental Autoimmune Encephalomyelitis in C57BL/6 and SJL Mice. The Journal of Immunology 2007;179(12):8470-8479.
78. Kerfoot SM. Reevaluation of P-Selectin and α4 Integrin as Targets for the Treatment of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 2006;176(10):6225-6234.
79. Vajkoczy P, Laschinger M, Engelhardt B. α4-integrin-VCAM-1 binding mediates G proteinâ€"independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. The Journal of Clinical Investigation 2001;108(4):557-565.
80. Alt C, Laschinger M, Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. European Journal of Immunology 2002;32(8): 2133-2144.
81. Lyck R. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 2003; 102(10):3675-3683.
82. Butcher EC. Lymphocyte Trafficking and Regional Immunity, in Advances in Immunology. Academic Press;1999.p 209-253.
83. Hickey WF, Kimura H. Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci U S A 1987;84(7):2082-6.
84. Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 2006;84(7):532-43.
85. Odoardi F, Kawakami N, Klinkert WEF, Wekerle H, FlÃ1/4gel A. Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease. Proceedings of the National Academy of Sciences 2007;104(47): 18625-18630.
86. Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11(2):125-37.
87. Hirschberg DL. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J Neuroimmunol 1998;89(1-2):88-96.
88. Archambault AS, Sim J, Gimenez MAT, Russell JH. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. European Journal of Immunology 2005; 35(4):1076-1085.
89. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009;9(6):393-407.
90. Becher B, Prat A, Antel JP. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 2000;29(4): 293-304.
91. Bö L. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. Journal of Neuroimmunology 1994;51(2):135-146.
92. Neumann H. Control of glial immune function by neurons. Glia 2001;36(2):191-9.
93. Zeinstra E, Wilczak N, Streefland C, De Keyser J. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 2000;11(1): 89-91.